Product Details for ANDA 202180
TRAZODONE HYDROCHLORIDE (TRAZODONE HYDROCHLORIDE)
50MG
Marketing Status: Prescription
100MG
Marketing Status: Prescription
150MG
Marketing Status: Prescription
300MG
Marketing Status: Prescription
50MG
Marketing Status: Prescription
Active Ingredient: TRAZODONE HYDROCHLORIDE
Proprietary Name: TRAZODONE HYDROCHLORIDE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 50MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A202180
Product Number: 001
Approval Date: Nov 27, 2013
Applicant Holder Full Name: TORRENT PHARMACEUTICALS LTD
Marketing Status: Prescription
Patent and Exclusivity Information
TRAZODONE HYDROCHLORIDE (TRAZODONE HYDROCHLORIDE)
Proprietary Name: TRAZODONE HYDROCHLORIDE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 50MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A202180
Product Number: 001
Approval Date: Nov 27, 2013
Applicant Holder Full Name: TORRENT PHARMACEUTICALS LTD
Marketing Status: Prescription
Patent and Exclusivity Information
100MG
Marketing Status: Prescription
Active Ingredient: TRAZODONE HYDROCHLORIDE
Proprietary Name: TRAZODONE HYDROCHLORIDE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 100MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A202180
Product Number: 002
Approval Date: Nov 27, 2013
Applicant Holder Full Name: TORRENT PHARMACEUTICALS LTD
Marketing Status: Prescription
Patent and Exclusivity Information
TRAZODONE HYDROCHLORIDE (TRAZODONE HYDROCHLORIDE)
Proprietary Name: TRAZODONE HYDROCHLORIDE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 100MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A202180
Product Number: 002
Approval Date: Nov 27, 2013
Applicant Holder Full Name: TORRENT PHARMACEUTICALS LTD
Marketing Status: Prescription
Patent and Exclusivity Information
150MG
Marketing Status: Prescription
Active Ingredient: TRAZODONE HYDROCHLORIDE
Proprietary Name: TRAZODONE HYDROCHLORIDE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 150MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A202180
Product Number: 003
Approval Date: Nov 27, 2013
Applicant Holder Full Name: TORRENT PHARMACEUTICALS LTD
Marketing Status: Prescription
Patent and Exclusivity Information
TRAZODONE HYDROCHLORIDE (TRAZODONE HYDROCHLORIDE)
Proprietary Name: TRAZODONE HYDROCHLORIDE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 150MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A202180
Product Number: 003
Approval Date: Nov 27, 2013
Applicant Holder Full Name: TORRENT PHARMACEUTICALS LTD
Marketing Status: Prescription
Patent and Exclusivity Information
300MG
Marketing Status: Prescription
Active Ingredient: TRAZODONE HYDROCHLORIDE
Proprietary Name: TRAZODONE HYDROCHLORIDE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 300MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A202180
Product Number: 004
Approval Date: Nov 27, 2013
Applicant Holder Full Name: TORRENT PHARMACEUTICALS LTD
Marketing Status: Prescription
Patent and Exclusivity Information
Proprietary Name: TRAZODONE HYDROCHLORIDE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 300MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A202180
Product Number: 004
Approval Date: Nov 27, 2013
Applicant Holder Full Name: TORRENT PHARMACEUTICALS LTD
Marketing Status: Prescription
Patent and Exclusivity Information